Agenus Inc. 2017 Annual Report 10-K

Agenus Inc.'s 2017 Form 10-K annual report disclosing financial performance, business operations, and risk factors for the immunotherapy and cancer vaccine company. The report covers fiscal year ended December 31, 2017, including discussion of the company's research and development efforts, product candidates, and regulatory compliance.